BNTC logo

BNTC Benitec Biopharma Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$7.92
-0.23 (-2.76%)

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single ad…

Market Cap: $285.88Mbenitec.com

Price

No data yet.

Social Signal Score

42
5d
—
30d
50
2 mentions
—
60d
41
4 mentions
—
90d
35
5 mentions
—
news: 5

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 1Sell 0Strong Sell 0
Avg price target$17+114.8%
Low $14Median $17High $20
Current Consensus

Revenue

$0.00-100.00%
$-40.0K$2.52M$5.08M$7.63M
Dec 2016Sep 2026

Analyst Estimates

FY2026
$-0.98
$-1.07–$-0.92
4 analysts
FY2027
$-1.21
$-1.31–$-1.07
6 analysts
FY2028
$-1.51
$-1.57–$-1.46
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jerel A. Banks
Sector
Healthcare
Industry
Biotechnology
Employees
24
Beta
0.24
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
25.30
benitec.com